Surescripts®, the nation’s leading health intelligence platform, has named the winners of the 2026 Surescripts White Coat Award™, recognizing healthcare organizations that advance prescription ...

Surescripts® and Oracle Health are working together to help remove the barriers that keep patients from starting the medication their care team prescribed. Through the partnership, Surescripts Prior ...

Surescripts, a health information exchange (HIE) network, has acquired ActiveRADAR, a health IT vendor that identifies therapeutic alternatives for prescriptions. Surescripts health information ...

Amazon-owned PillPack found a way to access its patients' prescription information via a third-party called ReMy Health. Surescripts, which contracts with ReMy, said this represents "unauthorized ...

Company earns sixth recognition from Modern Healthcare, reflecting a sustained commitment to people and purpose Surescripts®, the nation's leading health intelligence network, has been selected for ...

Surescripts just made it a lot harder for Amazon PillPack to recruit and retain its patients. The company said it is terminating its relationship with ReMy Health, a third party that supplied PillPack ...

Surescripts’ tool utilizes data from pharmacy benefit managers. Patients whose plans are connected to certain PBMs can then get their out-of-pocket cost for specific prescriptions. They can also get ...

The U.S. Federal Trade Commission on Wednesday announced that it is charging Surescripts with illegal monopolization of the market for e-prescriptions. “The FTC alleges that Surescripts intentionally ...

In response to the threat of legal action from Amazon’s PillPack for cutting off access to prescription data, Surescripts has booted the third-party vendor by which Amazon received the information ...

Surescripts has moved to dismiss the Federal Trade Commission's charge from earlier this year that it holds an illegal monopoly on the e-prescribing market. This past April, the FTC alleged that ...

Prior Authorization Automation returns approvals within seconds when all criteria are met for available medications, helping patients start therapy sooner.